News Articles and Montana BioScience Alliance Newsletters

MONTANA BIOSCIENCE ENTERPRISES IN THE NEWS

McLaughlin Research Institute
|
February 11, 2024

The grant money will launch the Center for Integrated Biomedical and Rural Health Research or CIB-RHR, expanding the research enterprise over the next five years, with the ultimate hope of bringing healthcare improvements to the state.

Sana Health and Lutroo Imaging emerged victorious among 70 competing startups and early-stage companies, securing the top honors at the inaugural American Academy of Pain Medicine (AAPM) and MIT Hacking Medicine Innovation Challenge presented by Abbott. Their success grants them the coveted opportunity to collaborate with Michael Hooten, M.D., president of AAPM and professor of Anesthesiology at the Mayo Clinic.

Montana Innovation Partnership
|
February 11, 2024

The Montana Innovation Partnership at Montana State University’s TechLink Center will host “Innovate Here,” a one-day virtual conference March 7 focused on key technology industries in Montana, such as bioscience, photonics and quantum technologies.  

Microbion recently announced another significant milestone in the development of its lead drug candidate, pravibismane. The U.S. FDA has granted pravibismane a second orphan drug designation for the treatment of non-tuberculous mycobacterial (NTM) infections.

BioSurface Technologies Corporation
|
January 30, 2024

In a recent dissertation by Carlos Jaser Lara de Larrea, the focus turns to practical solutions for a cleaner water future. The research, titled “Treatment of biofilms and opportunistic pathogens in simulated drinking water distribution systems using UV LEDs,” takes a straightforward approach to tackle biofilm issues in drinking water systems.

ARTICLES OF INTEREST

When her husband was undergoing cancer treatment, Cindy Perez of Southwest Ranches, Fla., learned about a new blood test that could help find early cancers. The 50-year-old said she felt fine, but her husband urged her to take the test anyway.

National Institutes of Health
|
March 26, 2024

Studies of interactions between two lab-generated monoclonal antibodies (mAbs) and an essential Epstein-Barr virus (EBV) protein have uncovered targets that could be exploited in designing treatments and vaccines for this extremely common virus.

BIO.News
|
January 30, 2024

As a new year begins in Congress, the Biotechnology Innovation Organization (BIO) is carrying over many of its legislative priorities from last year.

NIH National Institute on Aging
|
January 18, 2024

Administrative Supplements to Promote Diversity in Research and Development Small Businesses – SBIR/STTR

National Institutes of Health SEED
|
January 18, 2024

Contract Pre-solicitation for R&D that will contribute toward ARPA-H mission needs and SBIR program objectives.

NEWSLETTER

Newsletter
|
April 19, 2024

View the Spring 2024 Newsletter now!

Newsletter
|
February 20, 2024

View the Winter II 2024 Newsletter now!